Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 320 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. NDC 0378-5815-77.

D-0327-2019

December 04, 2018

Class II

Product summary

Firm
Mylan Laboratories Limited, (Nashik FDF)
Event
Event 81707
Status
Ongoing
Classification
Class II
Quantity
129,754 HDPE bottles
Official record key
drug-enforcement:D-0327-2019

Official wording

Reason: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Code information: Lot Numbers: 3063783 3063784 3063785 3064092 3064093 3064094 3070349 3070350 3070351 3070352 3070353 3070354 3079030 3079031 3079032 3079033 3080011 3080224 3081498 3081500 3087126 3088476

Distribution pattern: Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodiethylamine (NDEA